Načítá se...
The Effects of Rosiglitazone on Osteoblastic Differentiation, Osteoclast Formation and Bone Resorption
Rosiglitazone has the potential to activate peroxisome proliferator-activated receptor-γ (PPARγ), which in turn can affect bone formation and resorption. However, the mechanisms by which rosiglitazone regulates osteoclastic or osteoblastic differentiation are not fully understood. This study examine...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korea Society for Molecular and Cellular Biology
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3887713/ https://ncbi.nlm.nih.gov/pubmed/22286232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10059-012-2240-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|